| Symbol | FLNA |
|---|---|
| Name | FILANA THERAPEUTICS, INC. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX 78731 |
| Telephone | 512-501-2444 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001069530 |
| Description | None |
(30% Negative) FILANA THERAPEUTICS, INC. (FLNA) Reports Q2 2026 Financial Results
Read moreFilana Therapeutics Reports Q1 2026 Financial Results and Business Update
Read moreNew Form ARS - FILANA THERAPEUTICS, INC. <b>Filed:</b> 2026-04-28 <b>AccNo:</b> 0001437749-26-013656 <b>Size:</b> 1 MB
Read moreNew Form DEF 14A - FILANA THERAPEUTICS, INC. <b>Filed:</b> 2026-04-28 <b>AccNo:</b> 0001437749-26-013654 <b>Size:</b> 4 MB
Read moreFilana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data
Read moreFilana Therapeutics, Inc. - Common Stock (FLNA) was added to the exchange traded list on NASDAQ
Read more